You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRL Buy Disclosure
Coleman Glenn · SEC Form 4 · Filed Oct 2, 2026
Buy
Calculated transaction value
$2.97K
Coleman Glenn EVP & Chief Financial Officer
Transaction date
Sep 30, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 2 days later
CRL daily price context
Close on/before transaction
$295.01
Sep 30, 2026
First close after public filing
$310.77
Oct 5, 2026
30-day return after filing
+8.94%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10 shares @ $297.43
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001100682-26-000144
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$2.97K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Charles River Laboratories International, Inc. CRL Current | Buy | Sep 30, 2026 | $2.97K |